BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells

por Shimizu, Yoshiko, Mullins, Nicole, Blanchard, Zannel, ElShamy, Wael M.
Publicado 2012

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers

por Blanchard, Zannel, Paul, Bibbin T, Craft, Barbara, ElShamy, Wael M
Publicado 2015

Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions

por Rodriguez, Adriana C., Blanchard, Zannel, Maurer, Kathryn A., Gertz, Jason
Publicado 2019

Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer

por Blanchard, Zannel, Vahrenkamp, Jeffery M., Berrett, Kristofer C., Arnesen, Spencer, Gertz, Jason
Publicado 2019

Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs

por Arnesen, Spencer, Polaski, Jacob T, Blanchard, Zannel, Osborne, Kyle S, Welm, Alana L, O’Connell, Ryan M, Gertz, Jason
Publicado 2023

Geminin overexpression induces mammary tumors via suppressing cytokinesis

por Blanchard, Zannel, Malik, Rohit, Mullins, Nicole, Maric, Christine, Luk, Hugh, Horio, David, Hernandez, Brenda, Killeen, Jeffrey, ElShamy, Wael M.
Publicado 2011

Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative

por Blanchard, Zannel, Mullins, Nicole, Ellipeddi, Pavani, Lage, Janice M., McKinney, Shawn, El-Etriby, Rana, Zhang, Xu, Isokpehi, Raphael, Hernandez, Brenda, ElShamy, Wael M.
Publicado 2014

Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line

por Rush, Craig M., Blanchard, Zannel, Polaski, Jacob T., Osborne, Kyle S., Osby, Krystle, Vahrenkamp, Jeffery M., Yang, Chieh-Hsiang, Lum, David H., Hagan, Christy R., Leslie, Kimberly K., Pufall, Miles A., Thiel, Kristina W., Gertz, Jason
Publicado 2022